Sawai Group Holdings Co., Ltd. (4887.T)
Tokyo · JPY · Healthcare · Drug Manufacturers - Specialty & Generic
¥1,713 (-0.58%) as of
Key statistics
- Market cap
- 197.83B
- P/E (TTM)
- 20.73
- Forward P/E
- 10.01
- EPS (TTM)
- 82.63
- Dividend yield
- 3.25%
- 52-week range
- 1,550.50 – 2,447.00
- Revenue (TTM)
- 203.79B
- Profit margin
- 0.00%
- Analyst target
- ¥2,215.56
- Volume
- 422.30k
About Sawai Group Holdings Co., Ltd.
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the manufacture and sale of pharmaceuticals. The company offers generic drugs in various dosage forms for therapeutic areas comprising cardiovascular and antibiotic preparations, central nervous system drugs, other metabolic drugs, digestive tract medicines, blood and body fluid medications, allergy medications, respiratory medicine, vitamin supplements, oncology drugs, chemotherapeutic agents, genitourinary and anal drugs, and others. It sells its generic drugs through distributors, wholesalers, and retailers. Sawai Group Holdings Co., Ltd. was founded in 1929 and is headquartered in Osaka, Japan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Osaka, Japan
- Employees
- 3,630
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.